Successful oral chemotherapy with idarubicin in refractory anaemia with excess blasts
- 1 September 1987
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 39 (3), 278-281
- https://doi.org/10.1111/j.1600-0609.1987.tb00770.x
Abstract
6 patients with refractory anaemia with excess blasts (RAEB) were treated with a new oral anthracycline, idarubicin. 3 patients achieved complete remission, and the remaining 3 achieved partial remission. These responses were maintained for 8-60 wk, the longer durations being in the patients who achieved complete remission. Treatment was given on an outpatient basis, and all but 1 patient remained at home for most of the disease course. Unwanted effects were mild. It would appear that oral idarubicin is an effective treatment of RAEB, in addition to allowing outpatient management. Larger studies are required for further evaluation.Keywords
This publication has 10 references indexed in Scilit:
- Natural course of myelodysplastic syndromes — Helsinki experienceScandinavian Journal of Haematology, 1986
- Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromesBritish Journal of Haematology, 1984
- TREATMENT OF ADVANCED MYELODYSPLASTIC SYNDROME WITH ALFACALCIDOLThe Lancet, 1984
- Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemiaBritish Journal of Haematology, 1983
- Phase I study of 4-demethoxydaunorubicinInvestigational New Drugs, 1983
- PHASE-I CLINICAL-TRIAL OF 13-CIS-RETINOIC ACID IN MYELODYSPLASTIC SYNDROMES1983
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- EFFECT OF CHEMOTHERAPY FOR THE DYSMYELOPOIETIC SYNDROME1981
- Subacute myeloid leukemiaAmerican Journal Of Medicine, 1979